Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20307692rdf:typepubmed:Citationlld:pubmed
pubmed-article:20307692lifeskim:mentionsumls-concept:C0441635lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C1540140lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C1145667lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C0549178lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C0384782lld:lifeskim
pubmed-article:20307692lifeskim:mentionsumls-concept:C1707271lld:lifeskim
pubmed-article:20307692pubmed:issue7lld:pubmed
pubmed-article:20307692pubmed:dateCreated2010-5-24lld:pubmed
pubmed-article:20307692pubmed:abstractTextPolyglutamine tract-binding protein-1 (PQBP-1) is a nuclear protein that interacts with various proteins, including RNA polymerase II and the spliceosomal protein U5-15kD. PQBP-1 is known to be associated with X-linked mental retardation in which a frameshift mutation in the PQBP-1 gene occurs. In the present study, we demonstrate that PQBP-1 binds to U5-15kD via a continuous 23-residue segment within its C-terminal domain. Intriguingly, this segment is lost in the frameshift mutants of PQBP-1 associated with X-linked mental retardation. These findings suggest that the frameshift mutations in the PQBP-1 gene lead to expression of mutants lacking the ability to interact with U5-15kD.lld:pubmed
pubmed-article:20307692pubmed:languageenglld:pubmed
pubmed-article:20307692pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:citationSubsetIMlld:pubmed
pubmed-article:20307692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20307692pubmed:statusMEDLINElld:pubmed
pubmed-article:20307692pubmed:monthJullld:pubmed
pubmed-article:20307692pubmed:issn0006-3002lld:pubmed
pubmed-article:20307692pubmed:authorpubmed-author:AizawaTomoyas...lld:pubmed
pubmed-article:20307692pubmed:authorpubmed-author:KawanoKeiichi...lld:pubmed
pubmed-article:20307692pubmed:authorpubmed-author:DemuraMakotoMlld:pubmed
pubmed-article:20307692pubmed:authorpubmed-author:TakahashiMasa...lld:pubmed
pubmed-article:20307692pubmed:authorpubmed-author:OkazawaHitosh...lld:pubmed
pubmed-article:20307692pubmed:authorpubmed-author:MizuguchiMine...lld:pubmed
pubmed-article:20307692pubmed:authorpubmed-author:ShinodaHiroyu...lld:pubmed
pubmed-article:20307692pubmed:copyrightInfoCopyright (c) 2010 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:20307692pubmed:issnTypePrintlld:pubmed
pubmed-article:20307692pubmed:volume1804lld:pubmed
pubmed-article:20307692pubmed:ownerNLMlld:pubmed
pubmed-article:20307692pubmed:authorsCompleteYlld:pubmed
pubmed-article:20307692pubmed:pagination1500-7lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:meshHeadingpubmed-meshheading:20307692...lld:pubmed
pubmed-article:20307692pubmed:year2010lld:pubmed
pubmed-article:20307692pubmed:articleTitlePolyglutamine tract-binding protein-1 binds to U5-15kD via a continuous 23-residue segment of the C-terminal domain.lld:pubmed
pubmed-article:20307692pubmed:affiliationFaculty of Pharmaceutical Sciences, University of Toyama, 2630, Sugitani, Toyama 930-0194, Japan.lld:pubmed
pubmed-article:20307692pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20307692pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:10084entrezgene:pubmedpubmed-article:20307692lld:entrezgene
entrez-gene:10907entrezgene:pubmedpubmed-article:20307692lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20307692lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20307692lld:entrezgene